TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
TMDX

TransMedics Group Inc

Healthcare · Medical Devices

79.00$ -2.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

TransMedics Group Inc (TMDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,464 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TMDX
Line item Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 37 – 51 48 42 39 121 113 105 97 163 159 152 146 141 131 135 124 117 275 277 287 690 689 706 724 759 786 804 838 891 946 1,068 1,435 1,464
48 – – 34 25 47 43 35 30 116 107 100 92 158 154 147 141 135 126 119 106 95 251 252 262 663 537 511 488 509 492 497 506 558 613 638 619 651
-48 – – 12 -25 34 29 20 12 47 20 20 25 51 21 25 27 25 22 26 18 30 204 201 195 582 427 395 350 363 330 337 310 401 466 488 462 473
48 – – 25 25 35 29 20 12 96 88 81 73 139 133 126 118 112 103 92 72 58 204 201 195 582 427 395 350 363 330 337 310 401 466 488 462 473
– – – 0.9 – 2.7 3.9 3.4 5.1 7.1 6.5 6.6 6.1 4.4 6.1 6.9 7.4 6.3 4.2 5.9 12 13 22 28 39 48 61 64 82 81 90 98 142 105 81 84 91 104
– – – 8.0 – 9.0 9.6 9.3 11 11 11 11 11 13 13 12 12 13 15 15 17 17 19 21 24 31 39 44 49 49 52 47 43 39 45 49 50 54
– – – – – 3.2 3.3 3.5 3.8 4.4 4.7 4.8 4.7 4.4 4.7 4.8 4.7 5.0 5.1 16 12 16 18 24 19 27 – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – 0.0 – – 12 12 12 12 12 12 12 12 12 12 12 12
– – – – – – – – – – – – – – – – – – – – – – – – – – 2.4 2.4 2.3 2.3 2.2 2.2 2.1 2.1 2.0 1.9 – –
– – – 19 – 44 46 47 51 50 49 51 50 49 50 48 48 52 53 67 64 66 87 90 94 545 563 569 564 569 576 575 571 572 591 595 941 946
– – – 11 – 9.3 11 13 16 15 15 16 15 14 14 12 12 15 16 23 20 23 21 24 29 32 49 55 50 54 60 60 56 57 80 89 92 98
– – – 1.8 – – – – – – – – – – – – 35 35 – 8.6 1.3 1.4 1.4 1.4 1.5 1.9 2.0 2.0 2.1 2.1 2.5 2.7 2.8 3.0 8.2 13 19 24
– – – 3.5 – 2.7 3.7 4.7 5.5 6.7 4.8 7.2 4.9 3.7 0.8 1.2 1.3 2.4 2.7 6.7 2.9 5.7 3.1 3.3 4.3 7.0 13 13 9.2 13 13 10 11 9.5 12 10 11 71
– – – – – 33 34 34 34 34 34 34 34 34 35 35 35 35 35 35 35 35 59 59 59 505 505 506 507 508 509 509 510 511 507 502 498 494
39 – – 18 18 7.5 2.6 -4.8 -13 71 63 55 47 114 110 104 98 89 79 68 60 51 188 187 193 145 126 137 159 190 210 229 266 318 355 473 494 518
– – – -312 – -323 -328 -336 -343 -352 -360 -369 -378 -387 -392 -398 -406 -417 -430 -442 -453 -465 -472 -479 -481 -482 -508 -504 -492 -479 -475 -468 -443 -408 -383 -278 -271 -256
4.6 4.6 4.6 4.7 14 14 14 19 19 13 21 21 21 23 27 27 27 28 28 28 28 28 30 32 32 33 33 34 35 35 36 35 40 41 41 41 36 41

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?